Genomic analysis and mRNA expression of equine type i interferon genes

Journal of Interferon and Cytokine Research

Volumn 33, Issue 12, 2013, Pages 746-759

  Detournay, Olivier ^a   Morrison, David A ^b   Wagner, Bettina ^c   Zarnegar, Behdad ^a   Wattrang, Eva ^a  

^a NATIONAL VETERINARY INSTITUTE   (Sweden)

^b SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^c Cornell University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA OMEGA INTERFERON; BETA INTERFERON; DELTA INTERFERON; EPSILON INTERFERON; INTERFERON; KAPPA INTERFERON; MESSENGER RNA; MU INTERFERON; NU INTERFERON; OMEGA INTERFERON; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CHROMOSOME; CHROMOSOME 23; CONTROLLED STUDY; CYTOKINE RELEASE; FIBROBLAST; FUNCTIONAL GENOMICS; GENE; GENE EXPRESSION; GENE INDUCTION; GENE LOCUS; HORSE; IN VITRO STUDY; MOLECULAR PHYLOGENY; MULTIGENE FAMILY; NONHUMAN; NUCLEOTIDE SEQUENCE; PLACENTAL MAMMALS; PRIORITY JOURNAL; PSEUDOGENE; TYPE 1 INTERFERON GENE; VIRUS;

ANIMALS; CHROMOSOME MAPPING; GENE EXPRESSION; GENE ORDER; GENOMICS; HORSES; INTERFERON TYPE I; INTERFERON-ALPHA; MOLECULAR SEQUENCE ANNOTATION; MULTIGENE FAMILY; OPEN READING FRAMES; PHYLOGENY; RNA, MESSENGER;

EID: 84887037898     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2012.0130     Document Type: Article

References (57)

1. Chen J, Baig E, Fish EN. 2004. Diversity and relatedness among the type I interferons. J Interferon Cytokine Res 24(12): 687-698.
2. Chong YC, Duffus WP. 1992. Immune responses of specific pathogen free foals to EHV-1 infection. Vet Microbiol 32(3- 4): 215-228.
3. Cochet M, Vaiman D, Lefevre F. 2009. Novel interferon delta genes in mammals: cloning of one gene from the sheep, two genes expressed by the horse conceptus and discovery of related sequences in several taxa by genomic database screening. Gene 433(1-2): 88-99.
4. Colamonici OR, Domanski P, Platanias LC, Diaz MO. 1992. Correlation between interferon (IFN) alpha resistance and deletion of the IFN alpha/beta genes in acute leukemia cell lines suggests selection against the IFN system. Blood 80(3): 744-749.
5. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C. 2004. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303(5663): 1529-1531.
6. Edington N, Bridges CG, Griffiths L. 1989a. Equine interferons following exposure to equid herpesvirus-1 or - 4. J Interferon Res 9(4): 389-392.
7. Edington N, Bridges CG, Griffiths L. 1989b. Further investigations of equine interferons in vitro. J Interferon Res 9(4): 385-387.
8. Figueiredo MD, Salter CE, Andrietti AL, Vandenplas ML, Hurley DJ, Moore JN. 2009a. Validation of a reliable set of primer pairs for measuring gene expression by real-time quantitative RT-PCR in equine leukocytes. Vet Immunol Immunopathol 131(1-2): 65-72.
9. Figueiredo MD, Vandenplas ML, Hurley DJ, Moore JN. 2009b. Differential induction of MyD88- and TRIF-dependent pathways in equine monocytes by Toll-like receptor agonists. Vet Immunol Immunopathol 127(1-2): 125-134.
10. Fitzgerald-Bocarsly P, Dai J, Singh S. 2008. Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history. Cytokine Growth Factor Rev 19(1): 3-19.
11. Flaminio MJ, Borges AS, Nydam DV, Horohov DW, Hecker R, Matychak MB. 2007. The effect of CpG-ODN on antigen presenting cells of the foal. J Immune Based Ther Vaccines 5:1.
12. Garcia-Tapia D, Loiacono CM, Kleiboeker SB. 2006. Replication of West Nile virus in equine peripheral blood mononuclear cells. Vet Immunol Immunopathol 110(3-4): 229-244.
13. Hardy MP, Owczarek CM, Jermiin LS, Ejdebäck M, Hertzog PJ. 2004. Characterization of the type I interferon locus and identification of novel genes. Genomics 84(2): 331-345.
14. Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S, Lipford G, Wagner H, Bauer S. 2004. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303(5663): 1526-1529.
15. Himmler A, Hauptmann R, Adolf GR, Swetly P. 1986. Molecular cloning and expression in Escherichia coli of equine type I interferons. DNA 5(5): 345-356.
16. Hormanski CE, Truax R, Pourciau SS, Folsom RW, Horohov DW, Viveiros MM, Antczak DF. 1992. Induction of lymphokineactivated killer cells of equine origin: specificity for equine target cells. Vet Immunol Immunopathol 32(1-2): 25-36.
17. Horohov DW, Breathnach CC, Sturgill TL, Rashid C, Stiltner JL, Strong D, Nieman N, Holland RE. 2008. In vitro and in vivo modulation of the equine immune response by parapoxvirus ovis. Equine Vet J 40(5): 468-472.
18. Hughes AL. 1995. The evolution of the type I interferon gene family in mammals. J Mol Evol 41(5): 539-548.
19. Ito T, Kanzler H, Duramad O, Cao W, Liu YJ. 2006. Specialization, kinetics, and repertoire of type 1 interferon responses by human plasmacytoid predendritic cells. Blood 107(6): 2423-2431.
20. Jensen-Waern M, Persson SG, Nordengrahn A, Merza M, Fossum C. 1998. Temporary suppression of cell-mediated immunity in standardbred horses with decreased athletic capacity. Acta Vet Scand 39(1): 25-33.
21. Kato H, Sato S, Yoneyama M, Yamamoto M, Uematsu S, Matsui K, Tsujimura T, Takeda K, Fujita T, Takeuchi O, Akira S. 2005. Cell type-specific involvement of RIG-I in antiviral response. Immunity 23(1): 19-28.
22. Kawai T, Akira S. 2010. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11(5): 373-384.
23. Kerkmann M, Rothenfusser S, Hornung V, Towarowski A, Wagner M, Sarris A, Giese T, Endres S, Hartmann G. 2003. Activation with CpG-Aand CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells. J Immunol 170(9): 4465-4474.
24. Krause CD, Pestka S. 2005. Evolution of the Class 2 cytokines and receptors, and discovery of new friends and relatives. Pharmacol Ther 106(3): 299-346.
25. Krug A, Rothenfusser S, Hornung V, Jahrsdorfer B, Blackwell S, Ballas ZK, Endres S, Krieg AM, Hartmann G. 2001. Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells. Eur J Immunol 31(7): 2154-2163.
26. LaFleur DW, Nardelli B, Tsareva T, Mather D, Feng P, Semenuk M, Taylor K, Buergin M, Chinchilla D, Roshke V, Chen G, Ruben SM, Pitha PM, Coleman TA, Moore PA. 2001. Interferon- kappa, a novel type I interferon expressed in human keratinocytes. J Biol Chem 276(43): 39765-39771.
27. Land CE. 1974. Confidence interval estimation for means after data transformation to normality. J Am Stat Assoc 69(347): 795-802.
28. Leeb T, Vogl C, Zhu B, de Jong PJ, Binns MM, Chowdhary BP, Scharfe M, Jarek M, Nordsiek G, Schrader F, Blocker H. 2006. A human-horse comparative map based on equine BAC end sequences. Genomics 87(6): 772-776.
29. Lefevre F, Guillomot M, D'Andrea S, Battegay S, La Bonnardiere C. 1998. Interferon-delta: the first member of a novel type I interferon family. Biochimie 80(8-9): 779-788.
30. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(- Delta Delta C(T)) Method. Methods 25(4): 402-408.
31. Matsumiya T, Prescott SM, Stafforini DM. 2007. IFN-epsilon mediates TNF-alpha-induced STAT1 phosphorylation and induction of retinoic acid-inducible gene-I in human cervical cancer cells. J Immunol 179(7): 4542-4549.
32. Mignot CC, Pirottin D, Farnir F, de Moffarts B, Molitor C, Lekeux P, Art T. 2012. Effect of strenuous exercise and ex vivo TLR3 and TLR4 stimulation on inflammatory gene expression in equine pulmonary leukocytes. Vet Immunol Immunopathol 147(3-4): 127-135.
33. Morse DL, Carroll D, Weberg L, Borgstrom MC, Ranger-Moore J, Gillies RJ. 2005. Determining suitable internal standards for mRNA quantification of increasing cancer progression in human breast cells by real-time reverse transcriptase polymerase chain reaction. Anal Biochem 342(1): 69-77.
34. Nardelli B, Zaritskaya L, Semenuk M, Cho YH, LaFleur DW, Shah D, Ullrich S, Girolomoni G, Albanesi C, Moore PA. 2002. Regulatory effect of IFN-kappa, a novel type I IFN, on cytokine production by cells of the innate immune system. J Immunol 169(9): 4822-4830.
35. Onomoto K, Onoguchi K, Takahasi K, Fujita T. 2010. Type I interferon production induced by RIG-I-like receptors. J Interferon Cytokine Res 30(12): 875-881.
36. Pei J, Grishin NV. 2007. PROMALS: towards accurate multiple sequence alignments of distantly related proteins. Bioinformatics 23(7): 802-808.
37. Pestka S, Krause CD, Walter MR. 2004. Interferons, interferon- like cytokines, and their receptors. Immunol Rev 202(1): 8-32.
38. QuinlivanM, Zamarin D, Garcia-Sastre A, Cullinane A, Chambers T, Palese P. 2005. Attenuation of equine influenza viruses through truncations of theNS1 protein. J Virol 79(13): 8431-8439.
39. Rathinam VA, Fitzgerald KA. 2011. Innate immune sensing of DNA viruses. Virology 411(2):153-162.
40. Rozas J, Sanchez-DelBarrio JC, Messeguer X, Rozas R. 2003. DnaSP, DNA polymorphism analyses by the coalescent and other methods. Bioinformatics 19(18): 2496-2497.
41. Samarajiwa SA, Wilson W, Hertzog PJ. 2006. Type I interferons: genetics and structure. In: Meager A, ed. The interferons: characterization and application. Weinheim: Wiley-VCH. pp 3-34.
42. Sang Y, Rowland RR, Hesse RA, Blecha F. 2010. Differential expression and activity of the porcine type I interferon family. Physiol Genomics 42(2): 248-258.
43. Sorensen NS, Skovgaard K, Heegaard PM. 2011. Porcine blood mononuclear cell cytokine responses to PAMP molecules: comparison of mRNA and protein production. Vet Immunol Immunopathol 139(2-4): 296-302.
44. Stamatakis A. 2006. RAxML-VI-HPC: maximum likelihoodbased phylogenetic analyses with thousands of taxa and mixed models. Bioinformatics 22(21): 2688-2690.
45. Swofford DL. 2002. PAUP*: Phylogenetic analysis using parsimony (* and other methods). Sunderland, MA: Sinauer Associates.
46. Takaoka A, Yanai H. 2006. Interferon signalling network in innate defence. Cell Microbiol 8(6): 907-922.
47. Tornquist SJ, Oaks JL, Crawford TB. 1997. Elevation of cytokines associated with the thrombocytopenia of equine infectious anaemia. J Gen Virol 78(10): 2541-2548.
48. Vassileva G, Chen SC, Zeng M, Abbondanzo S, Jensen K, Gorman D, Baroudy BM, Jiang Y, Murgolo N, Lira SA. 2003. Expression of a novel murine type I IFN in the pancreatic islets induces diabetes in mice. J Immunol 170(11): 5748-5755.
49. Vollmer J, Weeratna R, Payette P, Jurk M, Schetter C, Laucht M, Wader T, Tluk S, Liu M, Davis HL, Krieg AM. 2004. Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities. Eur J Immunol 34(1): 251-262.
50. Wagner B, Hillegas JM, Flaminio MJBF, Wattrang E. 2008. Monoclonal antibodies to equine interferon-a (IFN-a): New tools to neutralize IFN activity and to detect secreted IFN-a. Vet Immunol Immunopathol 125(3-4): 315-325.
51. Wagner B, Wimer C, Freer H, Osterrieder N, Erb HN. 2011. Infection of peripheral blood mononuclear cells with neuropathogenic equine herpesvirus type-1 strain Ab4 reveals intact interferon-alpha induction and induces suppression of antiinflammatory interleukin-10 responses in comparison to other viral strains. Vet Immunol Immunopathol 143(1-2): 116-124.
52. Wattrang E, Berg M, Magnusson M. 2005. Immunostimulatory DNA activates production of type I interferons and interleukin- 6 in equine peripheral blood mononuclear cells in vitro. Vet Immunol Immunopathol 107(3-4): 265-279.
53. Wattrang E, Jessett DM, Yates P, Fuxler L, Hannant D. 2003. Experimental infection of ponies with equine influenza A2 (H3N8) virus strains of different pathogenicity elicits varying interferon and interleukin-6 responses. Viral Immunol 16(1): 57-67.
54. Wattrang E, Palm AK, Wagner B. 2012. Cytokine production and proliferation upon in vitro oligodeoxyribonucleotide stimulation of equine peripheral blood mononuclear cells. Vet Immunol Immunopathol 146(2): 113-124.
55. Woelk CH, Frost SD, Richman DD, Higley PE, Kosakovsky Pond SL. 2007. Evolution of the interferon alpha gene family in eutherian mammals. Gene 397(1-2): 38-50.
56. Yilma T, McGuire TC, Perryman LE. 1982. Preliminary characterization of equine interferons and their antiviral activities on bovine, ovine, and human cells. J Interferon Res 2(3): 363-370.
57. Zhao X, Cheng G, Yan W, Liu M, He Y, Zheng Z. 2009. Characterization and virus-induced expression profiles of the porcine interferon-omega multigene family. J Interferon Cytokine Res 29(10): 687-693.